Orchid Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE191A01027
  • NSEID: ORCHPHARMA
  • BSEID: 524372
INR
959.65
9.2 (0.97%)
BSENSE

Nov 20

BSE+NSE Vol: 70.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 653435,
    "name": "Orchid Pharma",
    "stock_name": "Orchid Pharma",
    "full_name": "Orchid Pharma Ltd",
    "name_url": "stocks-analysis/orchid-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "959.65",
    "chg": 9.2,
    "chgp": "0.97%",
    "dir": 1,
    "prev_price": "950.45",
    "mcapval": "5,749.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524372,
    "symbol": "ORCHPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE191A01027",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "70.15 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/orchid-pharma-653435-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Orchid Pharma Gains 8.87%: 3 Key Factors Driving the Week’s Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/orchid-pharma-gains-887-3-key-factors-driving-the-weeks-rally-4270687",
        "imagepath": "",
        "date": "2026-11-21 16:05:28",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Intraday high of Rs.980 with 7.09% surge</p>\n                    <p><strong>16 Nov:</strong> Significant gap up opening at +7.91%</p>\n                    <p><strong>17 Nov:</strong> Strong quarterly growth reported with 1383.4% PBT increase</p>\n                    <p><strong>20 Nov:</strong> Week closes at Rs.959.65, up 8.87%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.881.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.959.65</div><div class=\"stat-change po..."
      },
      {
        "title": "Orchid Pharma Ltd Reports Strong Quarterly Growth Amid Positive Financial Trend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/orchid-pharma-ltd-reports-strong-quarterly-growth-amid-positive-financial-trend-4264494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/OrchidPharmaLtd_fintrenddot_4264494.png",
        "date": "2026-11-17 08:00:08",
        "description": "Orchid Pharma Ltd has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, signalling a positive shift in its financial trend. The company’s latest results reveal robust revenue growth, significant profit expansion, and an upgraded Mojo Grade, reflecting renewed investor confidence in this small-cap pharmaceutical player."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-hold-by-marketsmojo-4261326",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/OrchidPharmaLtd_mojoScore_4261326.png",
        "date": "2026-11-14 10:10:41",
        "description": "Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-hold-4235092",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/OrchidPharmaLtd_mojoScore_4235092.png",
        "date": "2026-10-23 10:10:46",
        "description": "Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 August 2026. While this rating change occurred in mid-August, the analysis and financial metrics discussed here reflect the stock's current position as of 23 October 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-hold-4222547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/OrchidPharmaLtd_mojoScore_4222547.png",
        "date": "2026-10-12 10:10:44",
        "description": "Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 17 August 2026. While this rating change reflects the company’s evolving outlook, the analysis below is based on the stock’s current fundamentals, returns, and financial metrics as of 12 October 2026, providing investors with an up-to-date perspective on its investment potential."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-hold-4210974",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/OrchidPharmaLtd_mojoScore_4210974.png",
        "date": "2026-10-01 10:11:07",
        "description": "Orchid Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/orchid-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4207555",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/OrchidPharmaLtd_technicaldot_4207555.png",
        "date": "2026-09-29 08:04:18",
        "description": "Orchid Pharma Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a bullish to a mildly bullish trend. Despite a recent decline in price, the stock’s mixed technical signals suggest cautious optimism for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Orchid Pharma Gains 7.66%: 3 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/orchid-pharma-gains-766-3-key-factors-driving-the-weeks-momentum-4206093",
        "imagepath": "",
        "date": "2026-09-26 16:04:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>21 Sep:</strong> Intraday high surge with 7.28% gain</p>\n                    <p><strong>22 Sep:</strong> New 52-week high at Rs.1,138</p>\n                    <p><strong>22 Sep:</strong> Mojo Grade upgraded to Hold, bullish technical momentum</p>\n                    <p><strong>25 Sep:</strong> Week closes at Rs.1,064.85, up 7.66%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.989.10</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,064.85</div><div class=\"stat-change positive\">+7.6..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Orchid Pharma Ltd to 52-Week High of Rs 1138",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/orchid-pharma-ltd-hits-new-52-week-high-at-rs1138-4201318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/OrchidPharmaLtd_priceRelatedfactors_4201318.png",
        "date": "2026-09-22 10:18:23",
        "description": "With a decisive break above Rs 1138 on 22 Sep 2026, Orchid Pharma Ltd has reached a new 52-week high, extending its impressive 47.86% gain over the past year. This milestone comes amid a sustained rally that has seen the stock outperform its sector by nearly 5% today and gain almost 19% over the last three sessions."
      }
    ],
    "total": 71,
    "sid": "653435",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/orchid-pharma-653435"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "20-Nov-2026",
      "details": "Transcript of Analysts/Investor Earning call held with Public at large on November 17 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "17-Nov-2026",
      "details": "Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited (the Company)",
      "source": "BSE"
    },
    {
      "caption": "Board Comments On The Fine Levied By Stock Exchanges",
      "datetime": "16-Nov-2026",
      "details": "Board Comments on fine levied by Stock Exchanges",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Orchid Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 13 Sep 12",
          "dt": "2012-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

20-Nov-2026 | Source : BSE

Transcript of Analysts/Investor Earning call held with Public at large on November 17 2026

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

17-Nov-2026 | Source : BSE

Audio Recording of the Analysts/Investors Earnings Call - Orchid Pharma Limited (the Company)

Board Comments On The Fine Levied By Stock Exchanges

16-Nov-2026 | Source : BSE

Board Comments on fine levied by Stock Exchanges

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Orchid Pharma Ltd has declared 30% dividend, ex-date: 13 Sep 12

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available